Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study

Eric Lawitz, Charles Landis, Steven L. Flamm, Maurizio Bonacini, Grisell Ortiz‐Lasanta, Jonathan Huang, Jie Zhang, Brian J. Kirby, Shampa De-Oertel, Robert H. Hyland, Anu Osinusi, Diana M. Brainard, Richard A. Robson, Benedict Maliakkal, Stuart C. Gordon, Edward Gane